Equity news
8-
Gujarat themis biosyn: co signs agreement to acquire microbiopharm japan for approximately jpy 21.5 billion (13 billion rupees
-
Shah metacorp: approves $200,000 unsecured loan for shah metacorp holdings usa's working capital.
-
Lupin: company gets approval in china for oseltamivir phosphate oral suspension.
-
Sterlite technologies: subsidiary secures multi-year supply deal valued at approximately usd 1.11 billion or 10,000 cr rs. from a major partner for optical connectivity products to be completed by march 2029.
-
Moil limited: cancels work order worth 2.30 billion rupees.
-
Shilpa medicare: albumin's global phase 3 plan gets cdsco approval, aiming for impd submission to ema in first half of fy27.
-
Shilpa medicare: co. reports gmp facility qualification for adc is ongoing; facility set to start in 1q fy27.
-
Shilpa medicare: co. announces completion of lab development for teduglutide, with process validation batches expected by first half of fy27.
